Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 25, 2019 - Eli Lilly announced the withdrawal of Lartruvo (olaratumab) injection from the market.
Download PDF
Return to publications
